Drug discovery

Human liver
#Biosciences #Clinical trials #Drug discovery #Liver disease #Ochre Bio

Podcast: Unlock the potential of complex human liver data

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Quin Wills, Co-founder… Read More

#News

#Artificial intelligence (AI) #Drug discovery #Funding #Ginkgo #Immunology / Virology & Vaccines #Machine learning #Vaccine adjuvants

Ginkgo Bioworks to discover and develop novel vaccine adjuvants 

A five-year contract totalling up to $31 million including programme options has been awarded to Ginkgo Bioworks to discover and develop next-generation vaccine adjuvants. The contract was awarded by the Defense Threat Reduction Agency’s (DTRA) Joint Science and Technology Office (JSTO) for the Chemical and Biological Defense (CBD)… Read More

#News

Bill & Melinda Gates Foundation
#Bill & Melinda Gates Foundation #Drug development #Drug discovery #Finance #Funding #Mouse models #PhaSER Biomedical (PhaSER)

$2.3m Gates Foundation grant to accelerate global drug discovery 

Edinburgh-based PhaSER Biomedical (PhaSER) has received a Bill & Melinda Gates Foundation grant totalling $2.3m to continue its work in accelerating drug discovery and development.   PhaSER will provide 8HUM transgenic mouse models, humanised for key pathways involved in the metabolism and disposition of drugs, to all the… Read More

#News

#Advanced Therapies #Cell and gene therapy #Drug discovery #Webinar

DDW webinar: Global opportunities in cell and gene therapy

Hosted by DDW and sponsored by Astrea Bioseparations “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET.  … Read More

#News

Drug discovery innovation
#Drug discovery #ELRIG #Events #Medicines Discovery Catapult #Research

Keynotes announced for Research and Innovation 2024

The European Laboratory Research & Innovation Group (ELRIG) UK has announced the keynote speakers for its upcoming Research & Innovation conference: Steve Bates OBE FMedSci, CEO, BioIndustry Association (BIA) and Dr Anderson Ryan, Co-founder and Head of R&D and Drug Development, FasT BioPharma.   The event, taking place… Read More

#News

AI and robotics
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery

Is AI the answer to the challenges facing drug discovery?

DDW Editor Reece Armstrong asks whether artificial intelligence (AI) is the magic bullet many think it is. To reflect on another year in pharma is to think of the major stories and trends that have made impact within the industry. Often this can be drug approvals, exciting research… Read More

#Exclusive Content #Opinion

Cell and gene therapy
#Advanced Therapies #Cell and gene therapy #Drug discovery #Gene therapy #Webinar

Cell & gene therapies: How can market growth be sustained to maximise on opportunities?

In this on-demand webinar, hosted by DDW and sponsored by Astrea Bioseparations, learn about how market growth can be sustained to maximise on opportunities in cell and gene therapy (CGT). You will hear from Doug Danison, Head of Commercial Strategy and Operations for Bayer CGT, Mark Treherne, Commercial Research Scientist… Read More

Webinar date:
Sponsored by Astrea Bioseparations
#Webinars

2024 predictions, road forward
#2024 predictions #AI / data analytics / healthtech / informatics #Antiverse #Artificial intelligence (AI) #Drug discovery #Elsevier #Enhanc3D Genomics #IQVIA #Lab automation #Machine learning #Medidata #Ori Biotech #Technology #TrakCel #Trinity Life Sciences

2024 predictions: Experts comment on AI, ML and automation

DDW’s Megan Thomas spoke to experts from the drug discovery industry about their predictions on what 2024 holds for our sector. This is part of a series of predictions based on different themes. Here, experts weigh in on the impact of artificial intelligence (AI), machine learning (ML) and automation in… Read More

#Exclusive Content #Opinion #Trends & Analysis

Bacteria
#Aston University #Drug discovery #Funding #Microbiology #University of Warwick

UK university partnership wins £1.8m for drug discovery research

A team from Aston University and the University of Warwick has secured a £1.8 ($2.2) million grant to engineer microbial cell factories to produce membrane proteins which will support future drug screening and sustainable chemical production. The Engineering Biology Mission Award was given by UK Research… Read More

#News

Antibodies attacking virus
#Biomarkers #Drug discovery #Omics #Podcast #Proteins #Proteomics

Advancing precision medicine: Sengenics i-Ome Discovery microarrays

Professor Jonathan Blackburn, Chief Scientific Officer (CSO) of Sengenics, featured in a sponsored DDW Sitting Down With podcast to discuss the advantages of functional protein microarrays, challenges to overcome for biomarker discovery, Sengenics’ new i-Ome Discovery chip, and more. Professor Blackburn began by sharing an overview… Read More

#Exclusive Content

2024 predictions, road forward
#2024 predictions #AstraZeneca #BioSenic #Cancer #Drug discovery #Mosaic Therapeutics #Oncology #OrganaBio #Phesi #Therapeutics

2024 predictions: Experts weigh in on cancer research

DDW’s Megan Thomas spoke to experts from the drug discovery industry about their predictions on what 2024 holds for our sector. This is part of a series of predictions based on different themes. Here, experts weigh in on what to expect from cancer research and immunotherapies. Greg Rossi, Senior Vice… Read More

#Cancer Research #Exclusive Content #Opinion #Trends & Analysis

Cell and gene therapy concept
#Advanced Therapies #Cell and gene therapy #Drug discovery #Webinar

Cell and gene therapy market: Hear from the experts

Hosted by DDW and sponsored by Astrea Bioseparations “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET.   Join this… Read More

#News

Cell and gene therapy concept
#Advanced Therapies #Cell and gene therapy #Drug discovery #Webinar

Register now: Cell and gene therapy opportunities webinar

Hosted by DDW and sponsored by Astrea Bioseparations “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET.   Join this… Read More

#News

384-well microplate
#Aurora Microplates #Drug development #Drug discovery #Lab technology

High-performance microplates for discovery sciences

This paid-for advertorial by Aurora Microplates appeared in DDW Volume 25 – Issue 1, Winter 2023/2024 Aurora Microplates is 100% focused on making the highest quality, highest performing microplates available. Aurora uses the best materials, the cleanest and most precise moulding operations and facilities to deliver high-performance microplates in… Read More

#Exclusive Content